Related references
Note: Only part of the references are listed.Influence of the β-Sheet Content on the Mechanical Properties of Aggregates during Amyloid Fibrillization
Francesco Simone Ruggeri et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Anticancer and Anti-Inflammatory Properties of Chitin and Chitosan Oligosaccharides
Kazuo Azuma et al.
JOURNAL OF FUNCTIONAL BIOMATERIALS (2015)
Computational and Experimental Studies on β-Sheet Breakers Targeting A β1-40 Fibrils
Velia Minicozzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand et al.
NEUROPHARMACOLOGY (2014)
Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
Qiuming Wang et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Marine-derived Bioactive Materials for Neuroprotection
Ratih Pangestuti et al.
FOOD SCIENCE AND BIOTECHNOLOGY (2013)
Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric β-amyloid 1-42-induced neurotoxicity
Xueling Dai et al.
NEUROSCIENCE LETTERS (2013)
Chitosan Oligosaccharides Attenuates Oxidative-Stress Related Retinal Degeneration in Rats
I-Mo Fang et al.
PLOS ONE (2013)
Inhibitory effect of curcumin on the Al(III)-induced Aβ42 aggregation and neurotoxicity in vitro
Teng Jiang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Aβ-40 Y10F Increases βfibrils Formation but Attenuates the Neurotoxicity of Amyloid-β Peptide
Xueling Dai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines
Shao-wei Wang et al.
NEUROTOXICOLOGY (2012)
The Influence of Spin-Labeled Fluorene Compounds on the Assembly and Toxicity of the Aβ Peptide
Jitka Petrlova et al.
PLOS ONE (2012)
Preventing Alzheimer's Disease
Dennis J. Selkoe
SCIENCE (2012)
The Role of Tau in Alzheimer's Disease and Related Disorders
Rodrigo Medeiros et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Natural products as a source of Alzheimer's drug leads
Philip Williams et al.
NATURAL PRODUCT REPORTS (2011)
Amyloid by default
Lary C. Walker et al.
NATURE NEUROSCIENCE (2011)
Silibinin: A novel inhibitor of Aβ aggregation
Fei Yin et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Alzheimer's Disease: β-Amyloid Plaque Formation in Human Brain
Philip Seeman et al.
SYNAPSE (2011)
Chitosan oligosaccharides inhibit TNF-α-induced VCAM-1 and ICAM-1 expression in human umbilical vein endothelial cells by blocking p38 and ERK1/2 signaling pathways
Hong-Tao Liu et al.
CARBOHYDRATE POLYMERS (2010)
Preparation and characterization of toxic A beta aggregates for structural and functional studies in Alzheimer's disease research
Asad Jan et al.
NATURE PROTOCOLS (2010)
Molecular Insight into the Inhibition Effect of Trehalose on the Nucleation and Elongation of Amyloid β-Peptide Oligomers
Fu-Feng Liu et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Current and future therapy in Alzheimer's disease
Robert J. van Marum
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Cholinesterase inhibitors in the clinical management of Alzheimer's disease: Importance of early and persistent treatment
B. Seltzer
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2006)
Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42
R Liu et al.
NEUROBIOLOGY OF DISEASE (2005)
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
WB Stine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)